InChI=1S/C21H18BrNO3/c1-11(24)12-5-6-18-15(7-12)13-3-2-4-14(13)21(23-18)16-8-19-20(9-17(16)22)26-10-25-19/h2-3,5-9,13-14,21,23H,4,10H2,1H3/t13-,14+,21-/m1/s1 |
VHSVKVWHYFBIFJ-HKZYLEAXSA-N |
[H][C@]12CC=C[C@@]1([H])C1=C(N[C@H]2C2=CC3=C(OCO3)C=C2Br)C=CC(=C1)C(C)=O |
|
microtubule-destabilising agent
Any substance that interacts with tubulin to inhibit polymerisation of microtubules.
G-protein-coupled receptor agonist
An agonist that binds to and activates G-protein-coupled receptors
anti-obesity agent
Any substance which is used to reduce or control weight.
|
|
antineoplastic agent
A substance that inhibits or prevents the proliferation of neoplasms.
antihypertensive agent
Any drug used in the treatment of acute or chronic vascular hypertension regardless of pharmacological mechanism.
|
|
View more via ChEBI Ontology
1-[(3aS,4R,9bR)-4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinolin-8-yl]ethanone
|
881639-98-1
|
CAS Registry Number
|
SUBMITTER
|
34943948
|
PubMed citation
|
Europe PMC
|
36276488
|
PubMed citation
|
Europe PMC
|
36430793
|
PubMed citation
|
Europe PMC
|
38318490
|
PubMed citation
|
Europe PMC
|
38701557
|
PubMed citation
|
Europe PMC
|
38867416
|
PubMed citation
|
Europe PMC
|
38928205
|
PubMed citation
|
Europe PMC
|
|